Skip to content

PTSD research published in 2026

115 studies whose primary subject is PTSD have been published so far in 2026. Newest first. Back to the PTSD overview

Studies

Ketamine administration reduced conditioned defensive behaviour and upregulated protein expression associated with neuroplasticity in a planarian model of aversive memory reactivation.

Progress in neuro-psychopharmacology & biological psychiatry October 17, 2026 Fionnghuala L J James, Sayed K Ahamed, Cheng-I Yang et al.

Traumatic memories that are resistant to modification or extinction are a characteristic feature of post-traumatic stress disorder (PTSD). The process of fear memory reconsolidation has been identified as a potential therapeutic target for the treatment of PTSD. Ketamine, an NMDA receptor antagonist with dissociative properties, has been identified as a drug with high therapeutic potential for...

Efficacy and safety of ketamine for post‐traumatic stress disorder: A systematic review with narrative synthesis and consideration of military and veteran populations

Psychiatry and Clinical Neurosciences Reports October 7, 2026 Mary Ivasyutyn, Saajan Bhakta

Abstract Post‐traumatic stress disorder (PTSD) is a debilitating disorder with limited pharmaceutical treatment options. Ketamine, a noncompetitive N ‐methyl‐ d ‐aspartate (NMDA) receptor antagonist with rapid‐onset effects, has emerged as a potential treatment, particularly for patients who do not respond to first‐line therapies. This systematic review synthesizes the current evidence on the...

Multi-center, randomized controlled efficacy and comparative-effectiveness study evaluating ketamine, stellate ganglion blocks, combination treatment, and sham treatments for posttraumatic stress disorder and traumatic brain injury-associated headache: a study protocol

Pain Management October 1, 2026 Steven Paul Cohen, Roman Smolynets, Jordan Wood et al.

BACKGROUND: Posttraumatic stress disorder (PTSD) and traumatic brain injury (TBI) are conditions that share common mechanisms and are highly co-prevalent with each other and chronic pain. This pragmatic study will compare ketamine infusions to stellate ganglion blocks (SGB), their combination, and a placebo-sham-controlled arm. METHODS: A double-blind study conducted at 3 U.S. and Ukrainian...

Voided REM Sleep (V-REM): A Candidate Biomarker Linking Treatment-Resistant PTSD and Major Depressive Disorder

Preprints.org September 29, 2026 Mouhammad Ousmane Ndiaye preprint

A substantial proportion of patients with posttraumatic stress disorder (PTSD) and major depressive disorder (MDD) do not respond to first-line treatment. Approximately 40% of PTSD patients do not respond to first-line psychotherapy, and 30.9% of MDD patients meet criteria for treatment-resistant depression. Yet standard polysomnography in these patients frequently shows REM sleep that appears...

Recommending Meditation in Complex PTSD: Clinical Considerations

Journal of the American Psychiatric Nurses Association September 23, 2026 Jennifer Tustison

Objective: Posttraumatic stress disorder (PTSD) guidelines are often applied to complex PTSD (CPTSD), despite CPTSD’s distinct symptomatology. Core CPTSD symptoms, including affect dysregulation, negative self-concept, and relational disruption, may substantially alter treatment needs and safety considerations for mindfulness-based interventions. This article discusses clinical considerations...

Mindfulness and Posttraumatic Stress Symptoms in Mothers of Children With Pediatric Cancer

Clinical Practice in Pediatric Psychology September 17, 2026 Erinne R. Benedict, Hannah-Rose Mitchell

Background: Mothers are often identified as the primary caregiver, thus at unique risk for psychological sequelae of their child’s cancer, including elevated posttraumatic stress symptoms (PTSS). Studies have shown greater mindfulness is often associated with lower PTSS across populations. Methods: The current study examined associations between mothers’ mindfulness and its specific domains and...

The Nova Protocol: a comprehensive multimodal longitudinal study among civilian survivors of a mass trauma event.

European Journal of Psychotraumatology September 14, 2026 Roee Admon, Ophir Netzer, Noa Magal et al.

Background: The 7 October 2023 attack in southern Israel was one of the deadliest terror attacks in modern history, with 1,182 fatalities, more than 4,000 wounded individuals, and 251 hostages. The Nova music festival, an all-night outdoor rave near the Gaza border, suffered the highest number of civilian casualties, with more than 370 festival attendees killed. Survivors were exposed to...

[The use of psychedelics in psychiatry].

Orvosi hetilap September 13, 2026 Szabolcs Kéri

Over the past five years, the literature on the psychiatric use of psychedelic and related treatments has expanded substantially. Several randomized controlled trials and pooled analyses have been conducted in mood disorders, treatment-resistant depression, and post-traumatic stress disorder. Trial methodology, however, remains a fundamental source of uncertainty, and despite the popularity of...

A Systematic Review of MDMA’s Effects on Social Cognition in Placebo-Controlled Trials

PsyArXiv Preprints September 11, 2026 preprint

Background 3,4-Methylenedioxymethamphetamine (MDMA) is associated with distinctive prosocial and empathogenic effects, yet the consistency and scope of its impact on social cognition in humans remain unclear. Although numerous placebo-controlled studies have examined MDMA’s acute social effects, findings vary widely across subjective and behavioural domains. Methods We conducted a systematic...

DOI: osf:sgdau_v3 (opens in new tab) Full text (opens in new tab) MDMA PTSD 3 4-methylenedioxymethamphetamine Empathy +12

MDMA-Assisted Therapy May Decrease PTSD Symptoms, Dissociation, Depression, and Functional Disability: A Systematic Review and Meta-Analysis

Harvard Review of Psychiatry September 8, 2026 Warwick M. Green, Sanket B Raut, F. E. James et al.

There is a need for new effective treatment options for posttraumatic stress disorder (PTSD), as many people with PTSD do not fully recover despite current treatments. 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy (MDMA-AT) is emerging as a new treatment option. We assessed the current body of MDMA-AT evidence for effectiveness in treating PTSD, associated impairments, and...

Dronabinol for nightmares in post-traumatic stress disorder: a randomized controlled trial.

Nature Medicine September 2026 Stefan Roepke, Nikola Schoofs, Kathlen Priebe et al.

Nightmares are a hallmark of post-traumatic stress disorder (PTSD), yet pharmacological treatments remain limited. Here we conducted a multicenter, double-blind, randomized, placebo-controlled trial to evaluate the efficacy and safety of dronabinol (BX-1; Δ9-tetrahydrocannabinol (THC)) for PTSD-related nightmares. Adults with PTSD and recurrent nightmares were randomly assigned to receive...

Mindfulness-Based Interventions for Nurses: A Meta-Analysis of Effects on Compassion Fatigue, Job Burnout, and Traumatic Stress.

International Nursing Review September 1, 2026 Chao Wu, Lan Zhang, Xiaowei Xu

Aim: To evaluate the effectiveness of mindfulness-based interventions among nurses. Background: The demanding workload and high emotional investment inherent in nursing practice render nurses vulnerable to compassion fatigue, job burnout, and traumatic stress. Methods: A systematic literature search was conducted across major English and Chinese electronic databases. Eligibility criteria were...

DOI: 10.1111/inr.70245 (opens in new tab) Full text (opens in new tab) Mindfulness Humans Burnout, professional Stress disorders, traumatic +4

717. Clinical trials, ethical dimensions, and the pathway of MDMA-assisted therapy in PTSD

The International Journal of Neuropsychopharmacology September 1, 2026 Christopher Poppe, Dimitris Repantis

Abstract Background MDMA-assisted therapy (MDMA-AT) has shown promise for treatment-resistant post-traumatic stress disorder (PTSD), leveraging unique affective effects such as enhanced trust, empathy, and social connectedness. Despite preliminary efficacy, ethical challenges in clinical trials may directly affect regulatory approval and future clinical implementation. Aims & Objectives The...

Efficacy of a Digital Nonattachment-Based Intervention for Post-traumatic Stress Symptoms: A Randomised Controlled Trial

Mindfulness September 1, 2026 Lindsay Tremblay, William van Gordon, James Elander

Abstract Objectives Nonattachment, defined as the capacity to relate to internal experiences, identities, and external circumstances without clinging, avoidance, or over-identification, has been associated with reduced psychological distress and enhanced well-being, yet its deliberate cultivation within trauma-focused interventions remains underexplored. This study evaluated Nonattachment for...

PSYCHEDELICS IN THE TREATMENT OF POST-TRAUMATIC STRESS DISORDER AND DEPRESSION: A REVIEW OF CLINICAL TRIALS

International Journal of Innovative Technologies in Social Science August 31, 2026 Anna Szeszko, Weronika Maria Czernek, Magdalena Cichorzewska et al.

Psychedelic-assisted therapy has emerged as a prominent area for psychiatric investigation particularly with regards to treatment-resistant depression and Post Traumatic Stress Disorder (PTSD). The purpose of this narrative review was to outline the current body of research regarding psychedelic and psychedelic-like compounds in these two psychiatric conditions highlighting psilocybin-assisted...

The Mediating Role of Social Sensitivity in the Relationship Between Mindfulness and Secondary Traumatic Stress Among Social Media Users.

Psychological Reports August 24, 2026 Duygu Özer, Özlem Şahin Altun

Exposure to traumatic events such as disasters, violence, and wars through social media has been associated with psychological distress and secondary traumatic stress (STS). However, limited evidence exists regarding how mindfulness and social sensitivity are associated with this digital form of trauma. This study examined the relationships among mindfulness, social sensitivity, and STS among...

DOI: 10.1177/00332941261484082 (opens in new tab) Mindfulness Secondary traumatic stress Social sensitivity Social media users

An Embodied Model of Trauma Recovery: Examining Internal Regulatory Processes and Racial Stress in PTSD Among Black Americans

August 21, 2026 Ashanti J Brown

Black adults in the United States navigate profound and often invisible stressors at the intersection of racism and trauma. The burden of chronic racial stress functions as an embodied form of oppression that may increase the risk and intensity of post-traumatic stress disorder (PTSD) symptoms and undermine psychological strengths such as mindfulness and self-compassion for healing, recovery,...

Blood biomarker changes in response to low-dose oral ketamine treatment in adults with major depressive disorder (MDD) and post-traumatic stress disorder (PTSD)

medRxiv August 14, 2026 Annette M Braxton, Christina Driver, Daniel F. Hermens et al. preprint

Abstract Major depressive disorder (MDD) and post-traumatic stress disorder (PTSD) are prevalent, chronic, and disabling mental health conditions which are difficult to treat. Ketamine has demonstrated effect for improving depression and PTSD symptoms independently but reports often overlook focused comorbid improvement of these symptoms within individuals. To address this, we assessed...

MDMA-Enhanced Exposure Therapy Reverses PTSD-Like Features In a Learned Helplessness Mouse Model

bioRxiv (Cold Spring Harbor Laboratory) August 12, 2026 Orr Shahar, Perettz Golding, Masha Chaykin et al. preprint

Abstract Post-traumatic stress disorder (PTSD) is a highly prevalent, debilitating psychiatric condition. Existing treatments are ineffective for many patients. 3,4- methylenedioxymethamphetamine (MDMA)-assisted psychotherapy has demonstrated substantial clinical efficacy but relies on prolonged, resource-intensive therapeutic protocols that limit scalability and accessibility. Here, we...